Fulgent Genetics Earnings Estimate

By analyzing Fulgent Genetics' earnings estimates, investors can diagnose different trends across Fulgent Genetics' analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Fulgent Genetics is based on EPS before non-recurring items and includes expenses related to employee stock options. Fulgent Genetics is projected to generate -0.040475 in earnings per share on the 31st of December 2024. Fulgent Genetics earnings estimates show analyst consensus about projected Fulgent Genetics EPS (Earning Per Share). It derives the highest and the lowest estimates based on Fulgent Genetics' historical volatility. Many public companies, such as Fulgent Genetics, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing Fulgent Genetics' earnings estimates, investors can diagnose different trends across Fulgent Genetics' analyst sentiment over time as well as compare current estimates against different timeframes. At this time, Fulgent Genetics' Gross Profit is comparatively stable compared to the past year. Gross Profit Margin is likely to gain to 0.44 in 2025, despite the fact that Pretax Profit Margin is likely to grow to (0.51). Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fulgent Genetics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. For more information on how to buy Fulgent Stock please use our How to Invest in Fulgent Genetics guide.